Mr. Speaker, in reply to a question yesterday about the increase in the price of nitric oxide, the Parliamentary Secretary to the Minister of Health maintained that he could not take action because the Patented Medicine Prices Review Board is an independent quasi-judicial body.
I would like to point out to the Minister of Health that section 90 of the Patent Act authorizes him to refer matters to the Patented Medicine Prices Review Board for inquiry and to establish the time limits and terms of reference. What is the minister waiting for to take action?